Long-term effects of antilipidaemic therapy on left ventricular function in patients with dyslipidaemia: multigated radionuclide ventriculography study
Authors:
- Emre EntokEEEmre Entok
- Ahmet ÜnalirAÜAhmet Ünalir
- Yuksel CavusogluYCYuksel Cavusoglu
- Bilgin TimuralpBTBilgin Timuralp
- Erkan VardareliEVErkan Vardareli
- 1 September 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 26 (9) , 773-779
Abstract
It has been reported that dyslipidaemia impairs left ventricular systolic (LVs) and diastolic (LVd) functions, irrespective of atherogenic effects, in the setting of coronary artery disease. The aim of the present study was to evaluate the effects of anti-lipidaemic therapy on LVs and LVd functions by means of multigated radionuclide ventriculography (RNV) in subjects with signs of dyslipidaemia and with preserved left ventricular function. Eighteen patients with dyslipidaemia (eight men, 10 women, mean age 50+/-10 years) were included in the study. While the clinical examination and treadmill exercise test results were normal in all patients, low-density lipoprotein levels exceeded 160 mg . dl. Patients with medical conditions including coronary artery disease, hypertension, diabetes, cardiomyopathy and valvular heart disease which would influence left ventricular function were excluded from the study. RNV was performed in all subjects, taking into account the best septal position to differentiate the left ventricle from the right ventricle. The following parameters were calculated: ejection fraction, peak ejection rate (PER), time to peak ejection (TPER), a ejection rate (aER), a ejection fraction (aEF), Peak filling rate (PFR), time to peak filling rate (TPFR), a filling rate (aFR), a filling fraction (aFF). The low-density lipoprotein value decreased and the high-density lipoprotein value increased after statin therapy (P<0.001 and P<0.003, respectively). PER, aER and aFF significantly increased and TPER decreased as a consequence of statin therapy (respectively, P<0.05, P<0.05, P<0.05 P<0.05). Anti-lipidaemic therapy is effective in dyslipidaemic patients. RNV is a useful and non-invasive method for monitoring changes in ventricular function following anti-lipidaemic treatment strategies.Keywords
This publication has 69 references indexed in Scilit:
- Current Concepts of the Pathogenesis of the Acute Coronary SyndromesCirculation, 2001
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Quantitative Assessment of Coronary Vasoreactivity in Humans In VivoCirculation, 1995
- Longitudinal Gradients for Endothelium-Dependent and -Independent Vascular Responses in the Coronary MicrocirculationCirculation, 1995
- Contribution of Nitric Oxide to Metabolic Coronary Vasodilation in the Human HeartCirculation, 1995
- Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosisJACC, 1994
- Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery diseaseJACC, 1993
- Endothelial dysfunction in the coronary microcirculation: a new clinical entity or an experimental finding?Journal of Clinical Investigation, 1993
- Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis.Circulation, 1991
- Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates.Circulation, 1990